We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M Turnover 16.67%
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+26.61%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$139M
AUM Growth
+$13.2M
Cap. Flow
-$2.07M
Cap. Flow %
-1.49%
Top 10 Hldgs %
28.03%
Holding
140
New
16
Increased
30
Reduced
59
Closed
12
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.2 years
Top 20 Avg Time Held
0.2 years

Top Buys

Rank Stock Value
1
AXGN icon
Axogen
AXGN
+$1.48M
2
AAPL icon
Apple
AAPL
+$1.34M
3
REV
Revlon, Inc.
REV
+$1.28M
4
SUMR
Summer Infant, Inc.
SUMR
+$1.2M
5
NSPH
NANOSPHERE INC. COM NEW
NSPH
+$1.19M

Top Sells

Rank Stock Value
1
BEAT icon
BioTelemetry, Inc.
BEAT
+$3.26M
2
SAAS
inContact, Inc.
SAAS
+$1.41M
3
BLC
BELO CORP SER A
BLC
+$1.29M
4
CSII
Cardiovascular Systems, Inc.
CSII
+$1.11M
5
SPDC
SPEED COMMERCE, INC COM STK
SPDC
+$1.07M

Sector Composition

Rank Sector Weight
1 Healthcare 43.55%
2 Technology 15.19%
3 Miscellaneous 14.66%
4 Industrials 8.66%
5 Consumer Staples 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RMTI icon
1
Rockwell Medical
RMTI
$30.4M
$7.21M 5.19%
5,753
-1,470
-20% -$998K
2013 Q2
1 quarter
STJ
2
DELISTED
St Jude Medical
STJ
$4.97M 3.57%
92,638
+12,500
+16% +$644K
2013 Q2
1 quarter
UPI
3
DELISTED
UROPLASTY INC-NEW
UPI
$4.89M 3.52%
1,477,881
+5,560
+0.4% +$15.5K
2013 Q2
1 quarter
CSII
4
DELISTED
Cardiovascular Systems, Inc.
CSII
$4.67M 3.35%
232,699
-53,501
-19% -$1.11M
2013 Q2
1 quarter
ALT icon
5
Altimmune
ALT
$451M
$3.26M 2.34%
5,175
-121
-2% -$69.3K
2013 Q2
1 quarter
ZIXI
6
DELISTED
Zix Corporation
ZIXI
$3.22M 2.31%
656,777
+3,000
+0.5% +$13.5K
2013 Q2
1 quarter
RIOT icon
7
Riot Platforms
RIOT
$5.24B
$2.83M 2.03%
182,103
+23,707
+15% +$289K
2013 Q2
1 quarter
DTLK
8
DELISTED
Datalink Corp
DTLK
$2.8M 2.01%
206,800
+18,950
+10% +$240K
2013 Q2
1 quarter
HILL
9
DELISTED
DOT HILL SYSTEMS CORP
HILL
$2.63M 1.89%
1,229,699
-31,644
-3% -$77.4K
2013 Q2
1 quarter
SPDC
10
DELISTED
SPEED COMMERCE, INC COM STK
SPDC
$2.53M 1.82%
771,261
-332,739
-30% -$1.07M
2013 Q2
1 quarter
AIFC icon
11
AI Financial Corp
AIFC
$54.4M
$2.51M 1.8%
170,024
– –
2013 Q2
1 quarter
SVU
12
DELISTED
SUPERVALU Inc.
SVU
$2.51M 1.8%
43,493
-71
-0.2% -$3.74K
2013 Q2
1 quarter
CCIX
13
DELISTED
COLEMAN CABLE IN COM
CCIX
$2.47M 1.77%
116,850
-500
-0.4% -$10.2K
2013 Q2
1 quarter
SNAK
14
DELISTED
Inventure Foods, Inc.
SNAK
$2.45M 1.76%
233,500
– –
2013 Q2
1 quarter
HNSN
15
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$2.24M 1.61%
124,991
-38,724
-24% -$609K
2013 Q2
1 quarter
OESX icon
16
Orion Energy Systems
OESX
$96.3M
$2.18M 1.57%
58,013
+480
+0.8% +$16.4K
2013 Q2
1 quarter
LFVN icon
17
LifeVantage
LFVN
$76M
$2.05M 1.47%
122,810
– –
2013 Q2
1 quarter
CTG
18
DELISTED
Computer Task Group, Inc.
CTG
$1.99M 1.43%
122,900
– –
2013 Q2
1 quarter
IONS icon
19
Ionis Pharmaceuticals
IONS
$7.32B
$1.98M 1.43%
52,850
-13,900
-21% -$415K
2013 Q2
1 quarter
PFE icon
20
Pfizer
PFE
$169B
$1.94M 1.4%
71,324
-4,855
-6% -$132K
2013 Q2
1 quarter
CNSY icon
21
Cerenome
CNSY
$13.2M
– –
0
– –
2013 Q2
1 quarter
VYX icon
22
NCR Voyix
VYX
$1B
$1.83M 1.32%
75,469
-163
-0.2% -$3.65K
2013 Q2
1 quarter
XTNT icon
23
Xtant Medical Holdings
XTNT
$44.7M
$1.81M 1.3%
22,489
+8,145
+57% +$585K
2013 Q2
1 quarter
AXGN icon
24
Axogen
AXGN
$2.11B
$1.79M 1.29%
+403,000
New +$1.48M
2013 Q3
0 quarters
PLUS icon
25
ePlus
PLUS
$2.51B
$1.76M 1.26%
136,000
– –
2013 Q2
1 quarter
1
2 3 4 5

Similar funds

AA
Alpha Advisors Richmond, Virginia $133M AUM 20.23% 1-Year Est. Return
WA
Winter & Associates St. Paul, Minnesota $133M AUM
AC
Aldebaran Capital Carmel, Indiana $133M AUM 42.18% 1-Year Est. Return
BCVI
Bain Capital Venture Investors Boston, Massachusetts $133M AUM 50.19% 1-Year Est. Return
HAP
Harbor Asset Planning Belmont, Massachusetts $133M AUM 24.86% 1-Year Est. Return
RHIG
R.H. Investment Group Scottsdale, Arizona $133M AUM 23.61% 1-Year Est. Return
CWM
Capstone Wealth Management Billings, Montana $133M AUM
SI
Severin Investments St. Louis, Missouri $133M AUM 45.69% 1-Year Est. Return

Perkins Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Perkins Capital Management held 140 positions worth $139M, up 10% from $126M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Perkins Capital Management's Q3 2013 filing shows 16 new, 30 increased, 59 reduced and 12 closed positions. Its largest new stake was Axogen: 403,000 shares worth $1.79M. The largest sale was BioTelemetry, Inc., an estimated $3.26M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 40% a quarter earlier, followed by Technology and Miscellaneous.

  • Perkins Capital Management's largest Q3 2013 buy was Axogen: 403,000 shares worth $1.79M.
  • Perkins Capital Management added most to Summer Infant, Inc. in Q3 2013, an estimated $1.2M increase.
  • Perkins Capital Management's biggest Q3 2013 reduction was BioTelemetry, Inc., cutting an estimated $3.26M.
  • Perkins Capital Management fully exited BELO CORP SER A in Q3 2013, selling an estimated $1.29M.
  • Perkins Capital Management's ten largest holdings make up 28% of its $139M portfolio in Q3 2013.
  • Perkins Capital Management opened 16 new positions and closed 12 in Q3 2013.
  • Perkins Capital Management's portfolio value rose 10% quarter-over-quarter to $139M.

Based on Perkins Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.